Advancing Equitable COVID-19 Vaccination in Humanitarian Crisis
Health hera Health hera

Advancing Equitable COVID-19 Vaccination in Humanitarian Crisis

The World Health Organization (WHO), taking the lead in responding to this pressing issue, selected hera to conduct a study on the complexities of COVID-19 vaccine deployment and administration in humanitarian settings, with a specific focus on populations of concern (PoC). The study was initiated in March 2022 and concluded in March 2023, and encompassed case studies in multiple countries deeply affected by humanitarian crises: Cox's Bazar (Bangladesh), Colombia, the Democratic Republic of the Congo (DRC), Iraq, South Sudan, and Syria.

Read More
hera to support Health Systems Global in developing a new 5-year strategic plan
Health, Development hera Health, Development hera

hera to support Health Systems Global in developing a new 5-year strategic plan

A hera team, led by CEO Leen Jille and Associate Partner Giorgia Lattanzi, has been selected to support Health Systems Global (HSG) in developing its next 5-Year Strategic plan covering 2021-2026. The aim is to develop a strategic framework that continues to position HSG at “the forefront of health systems policy and research within the changing landscape of global health.”

Read More
Mid-term review of the EU/ACP/WHO Renewed Partnership for strengthening pharmaceutical systems and improving access to quality medicines in 15 African ACP Countries
Health hera Health hera

Mid-term review of the EU/ACP/WHO Renewed Partnership for strengthening pharmaceutical systems and improving access to quality medicines in 15 African ACP Countries

The “The Renewed EU/ACP/WHO Partnership” (RP) was a four year programme (October 2012 – September 2016) with the overall objective to contribute to the achievement of health-related MDGs and to universal health coverage in African ACP countries by improving the availability, affordability and use of safe, effective and quality assured essential medicines for the treatment of priority acute and non-communicable diseases.

Read More
Assessing the Impact: BMGF & DFID's Reproductive Health Programmes in Low- and Middle-Income Countries
Health hera Health hera

Assessing the Impact: BMGF & DFID's Reproductive Health Programmes in Low- and Middle-Income Countries

In an effort to promote reproductive health and accessibility to quality-assured reproductive health commodities in low- and middle-income countries, the Bill & Melinda Gates Foundation (BMGF) and the Department for International Development (DFID), now known as the Foreign, Commonwealth & Development Office (FCDO), rolled out two independent, yet complementary, programmes geared towards ensuring hormonal contraceptives become more readily available, of high quality and affordable.

Read More